Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer.
Shu R, Evtimov VJ, Hammett MV, Nguyen NN, Zhuang J, Hudson PJ, Howard MC, Pupovac A, Trounson AO, Boyd RL.
Shu R, et al. Among authors: zhuang j.
Mol Ther Oncolytics. 2021 Jan 16;20:325-341. doi: 10.1016/j.omto.2021.01.002. eCollection 2021 Mar 26.
Mol Ther Oncolytics. 2021.
PMID: 33614914
Free PMC article.